The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.

PROsetta: Linking Patient-Reported Outcomes Measures

Perform scale linking to establish relationships between instruments that measure similar constructs according to the PROsetta Stone methodology, as in Choi, Schalet, Cook, & Cella (2014) <doi:10.1037/a0035768>.

Version: 0.4.1
Depends: R (≥ 3.5.0)
Imports: Rcpp (≥ 1.0.0), equate, lavaan, mirt, plink, psych, methods, mvnfast, TestDesign (≥ 1.5.1)
LinkingTo: Rcpp, RcppArmadillo
Suggests: shiny, shinythemes, shinyWidgets, shinyjs, DT, knitr, kableExtra, testthat (≥ 2.1.0), rmarkdown, dplyr, pkgdown
Published: 2023-02-03
DOI: 10.32614/CRAN.package.PROsetta
Author: Seung W. Choi ORCID iD [aut, cre], Sangdon Lim ORCID iD [aut], Benjamin D. Schalet [ctb], Aaron J. Kaat [ctb], David Cella [ctb]
Maintainer: Seung W. Choi <schoi at austin.utexas.edu>
BugReports: https://github.com/choi-phd/PROsetta/issues
License: GPL-3
URL: https://www.prosettastone.org/ (project description), https://choi-phd.github.io/PROsetta/ (documentation)
NeedsCompilation: yes
SystemRequirements: C++17
Citation: PROsetta citation info
Materials: README NEWS
In views: Psychometrics
CRAN checks: PROsetta results

Documentation:

Reference manual: PROsetta.pdf
Vignettes: Scale linking with PROsetta package

Downloads:

Package source: PROsetta_0.4.1.tar.gz
Windows binaries: r-devel: PROsetta_0.4.1.zip, r-release: PROsetta_0.4.1.zip, r-oldrel: PROsetta_0.4.1.zip
macOS binaries: r-release (arm64): PROsetta_0.4.1.tgz, r-oldrel (arm64): PROsetta_0.4.1.tgz, r-release (x86_64): PROsetta_0.4.1.tgz, r-oldrel (x86_64): PROsetta_0.4.1.tgz
Old sources: PROsetta archive

Linking:

Please use the canonical form https://CRAN.R-project.org/package=PROsetta to link to this page.

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.